Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05645406Phase 1Completed
Phase 1, open-label trial of estradiol topical in menopause (2 arms), sponsored by University of Maryland, Baltimore. Primary endpoint: Pharmacokinetics. Started May 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05645406.